StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bionano Genomics's price to sales ratio was 0.4× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.2× to 53.7×, with a median of 1.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.1
2025Dec 31, 20250.5×−0.2
2024Dec 31, 20240.8×−1.2
2023Dec 29, 20232.0×−14.8
2022Dec 30, 202216.7×−37.0
2021Dec 31, 202153.7×−8.9
2020Dec 31, 202062.6×+61.4
2019Dec 31, 20191.2×−3.7
2018Dec 31, 20184.9×–

More Bionano Genomics figures

See a number that looks wrong?